Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroyoshi Nishikawa

Showing results (71-80 of 197) with videos related to

Pageof 20
Sort By:
Advances in Cancer Research|July 25, 2006
NY-ESO-1: review of an immunogenic tumor antigenSacha Gnjatic, Hiroyoshi Nishikawa, Achim A Jungbluth, et al.
Plos One|August 12, 2016
Antibody to CMRF35-Like Molecule 2, CD300e A Novel Biomarker Detected in Patients with Fulminant Type 1 DiabetesFumitaka Haseda, Akihisa Imagawa, Hiroyoshi Nishikawa, et al.
The Journal of Experimental Medicine|September 21, 2019
Selective inhibition of low-affinity memory CD8<sup>+</sup> T cells by corticosteroidsAkihiro Tokunaga, Daisuke Sugiyama, Yuka Maeda, et al.
Science (New York, N.Y.)|December 20, 2014
Detection of self-reactive CD8⁺ T cells with an anergic phenotype in healthy individualsYuka Maeda, Hiroyoshi Nishikawa, Daisuke Sugiyama, et al.
Cytotherapy|March 20, 2012
Peptide-pulsed dendritic cell vaccination targeting interleukin-13 receptor α2 chain in recurrent malignant glioma patients with HLA-A*24/A*02 alleleKenichiro Iwami, Shinji Shimato, Masasuke Ohno, et al.
International Journal of Cancer|June 26, 2012
Induction of CD8 T-cell responses restricted to multiple HLA class I alleles in a cancer patient by immunization with a 20-mer NY-ESO-1f (NY-ESO-1 91-110) peptideShingo Eikawa, Kazuhiro Kakimi, Midori Isobe, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|June 3, 2018
Clinicopathological features of 22C3 PD-L1 expression with mismatch repair, Epstein-Barr virus status, and cancer genome alterations in metastatic gastric cancerAkihito Kawazoe, Kohei Shitara, Yasutoshi Kuboki, et al.
JCI Insight|January 9, 2025
Sustained inhibition of CSF1R signaling augments antitumor immunity through inhibiting tumor-associated macrophagesTakahiko Sato, Daisuke Sugiyama, Jun Koseki, et al.
The Journal of Experimental Medicine|March 9, 2005
Definition of target antigens for naturally occurring CD4(+) CD25(+) regulatory T cellsHiroyoshi Nishikawa, Takuma Kato, Isao Tawara, et al.
Immunity|December 9, 2014
Interleukin-10-producing plasmablasts exert regulatory function in autoimmune inflammationMasanori Matsumoto, Akemi Baba, Takafumi Yokota, et al.
Pageof 20

Showing results (71-80 of 197) with videos related to

Sort By:
Pageof 20
Advances in Cancer Research|July 25, 2006
NY-ESO-1: review of an immunogenic tumor antigenSacha Gnjatic, Hiroyoshi Nishikawa, Achim A Jungbluth, et al.
Plos One|August 12, 2016
Antibody to CMRF35-Like Molecule 2, CD300e A Novel Biomarker Detected in Patients with Fulminant Type 1 DiabetesFumitaka Haseda, Akihisa Imagawa, Hiroyoshi Nishikawa, et al.
The Journal of Experimental Medicine|September 21, 2019
Selective inhibition of low-affinity memory CD8<sup>+</sup> T cells by corticosteroidsAkihiro Tokunaga, Daisuke Sugiyama, Yuka Maeda, et al.
Science (New York, N.Y.)|December 20, 2014
Detection of self-reactive CD8⁺ T cells with an anergic phenotype in healthy individualsYuka Maeda, Hiroyoshi Nishikawa, Daisuke Sugiyama, et al.
Cytotherapy|March 20, 2012
Peptide-pulsed dendritic cell vaccination targeting interleukin-13 receptor α2 chain in recurrent malignant glioma patients with HLA-A*24/A*02 alleleKenichiro Iwami, Shinji Shimato, Masasuke Ohno, et al.
International Journal of Cancer|June 26, 2012
Induction of CD8 T-cell responses restricted to multiple HLA class I alleles in a cancer patient by immunization with a 20-mer NY-ESO-1f (NY-ESO-1 91-110) peptideShingo Eikawa, Kazuhiro Kakimi, Midori Isobe, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|June 3, 2018
Clinicopathological features of 22C3 PD-L1 expression with mismatch repair, Epstein-Barr virus status, and cancer genome alterations in metastatic gastric cancerAkihito Kawazoe, Kohei Shitara, Yasutoshi Kuboki, et al.
JCI Insight|January 9, 2025
Sustained inhibition of CSF1R signaling augments antitumor immunity through inhibiting tumor-associated macrophagesTakahiko Sato, Daisuke Sugiyama, Jun Koseki, et al.
The Journal of Experimental Medicine|March 9, 2005
Definition of target antigens for naturally occurring CD4(+) CD25(+) regulatory T cellsHiroyoshi Nishikawa, Takuma Kato, Isao Tawara, et al.
Immunity|December 9, 2014
Interleukin-10-producing plasmablasts exert regulatory function in autoimmune inflammationMasanori Matsumoto, Akemi Baba, Takafumi Yokota, et al.
Pageof 20